Furthermore, IL-13 has been shown to significantly modulate respiratory syncytial virus infection, including decreasing the viral titers, inhibiting the lung IFN-γ production, and reducing weight loss, as well as affecting viral entry, replication, and cell-to-cell transmission (45). Here, IL13 is linked to respiratory syncytial virus infectious disease.